MRESInstitute of Biomedical Research Corp.

About Institute of Biomedical Research Corp. (MRES)

Institute of Biomedical Research Corp. (MRES) is a Biotechnology company headquartered in Dubai, United Arab Emirates whose shares trade over-the-counter on the Pink tier.

The Institute of Biomedical Research is a Nevada Corporation trading as M2Bio Science. We are a bioceutical company focused on alternative plant-based food and medicine and mental health therapeutic research. M2Bio's mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. M2Bio is actively conducting research to prove the science behind its product range. Other company divisions include M2BiomeTM Cardiometabolic Health, M2Enviro, M2Sentient, and M2MMA. The company owns and operates the consumer goods brands Dr. AnnaRx™, and Liviana™. The brands span across a wide range of premium consumer goods including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Dubai, United Arab Emirates and Cape Town, South Africa the company and its brands are positioned in the high-value market segment. The company is also the controlling shareholder, with a majority stake in Real American Capital Corporation (OTC: "RLAB"). RLAB stages mixed martial arts events and is also at the forefront of the use of artificial intelligence in areas such as traumatic brain injuries.

Products and services

M2Bio company divisions include M2Bio Food and Beverage, M2BiomeTM Cardiometabolic Health, M2Enviro, M2Sentient, and M2MMA. The company owns and operates the consumer goods brands Dr. AnnaRx™, and Liviana™. The brands span across a wide range of premium consumer goods including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Dubai, United Emirates and Cape Town, South Africa the company and its brands are positioned in the high-value market segment.

MRES key facts

Ticker symbol

MRES

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Dubai, United Arab Emirates

Country of incorporation

US

Year of incorporation

1990

Employees

10

Estimated market cap

$39.10M (as of Apr 9, 2025)

Shares outstanding

2,399,024,113

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

3/31

Latest filing

Quarterly Report (Dec 31, 2024)

Institute of Biomedical Research Corp. leadership

• Peter Jeffrey Robinson — CEO, President
• Willem Daniel Jonker — CFO
• Dr. Anna Morera Leralta — Chief Med. Officer, Secretary

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with M